34 KiB
title, docid, authors, breadcrumbs, category, cmeTopicId, documentVersionId, imageCount, lastUpdated, pageDescription, pageKeywords, pageTitle, enhancedTitle, type, references, breadcrumbs
| title | docid | authors | breadcrumbs | category | cmeTopicId | documentVersionId | imageCount | lastUpdated | pageDescription | pageKeywords | pageTitle | enhancedTitle | type | references | breadcrumbs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pilomyxoid Astrocytoma | 7208af53-1e09-411a-951d-1ea7bd40be53 |
|
|
Pediatrics | 34d90a10-f275-4f55-922b-0f89af8cba2b | 614c8777-1be1-46f0-acce-655cdd80afc3 | 29 | 02/09/24 | Pilomyxoid Astrocytoma | Pediatrics, Diagnosis, Pediatric Neuroradiology, Brain, Pathology-Based Diagnoses, Neoplasms, Pilomyxoid Astrocytoma | Pilomyxoid Astrocytoma | STATdx | Pilomyxoid Astrocytoma | DX | true |
|
title: "Pilomyxoid Astrocytoma" docid: "7208af53-1e09-411a-951d-1ea7bd40be53" authors:
- key: "47381de4-c9fd-4999-8dd0-1808cd72db6b" value: "Luke L. Linscott, MD"
- key: "5cff4116-3654-4b3a-bb75-5ebe0b8c9850" value: "Anne G. Osborn, MD, FACR" breadcrumbs:
- name: "Pediatrics" slug: "pediatrics" treeNodeId: "a915965c-d436-44cf-ae65-2f22e7246ea4"
- name: "Diagnosis" slug: "diagnosis" treeNodeId: "2b5cea64-a083-489e-ac0c-ec14ba059026"
- name: "Pediatric Neuroradiology" slug: "pediatric-neuroradiology" treeNodeId: "d0eb8f4a-e769-43dd-896c-8c9c27ce8759"
- name: "Brain" slug: "brain" treeNodeId: "feaaadba-649b-4f0a-9aad-9188a8f9926a"
- name: "Pathology-Based Diagnoses" slug: "pathology-based-diagnoses" treeNodeId: "2d26053f-23a7-4062-bf35-a93775ae1209"
- name: "Neoplasms" slug: "neoplasms" treeNodeId: "753a271a-f539-4662-a805-059486e3c267"
- name: "Pilomyxoid Astrocytoma" slug: "pilomyxoid-astrocytoma" treeNodeId: null category: "Pediatrics" cmeTopicId: "34d90a10-f275-4f55-922b-0f89af8cba2b" documentVersionId: "614c8777-1be1-46f0-acce-655cdd80afc3" imageCount: 29 lastUpdated: "02/09/24" pageDescription: "Pilomyxoid Astrocytoma" pageKeywords: "Pediatrics, Diagnosis, Pediatric Neuroradiology, Brain, Pathology-Based Diagnoses, Neoplasms, Pilomyxoid Astrocytoma" pageTitle: "Pilomyxoid Astrocytoma | STATdx" enhancedTitle: "Pilomyxoid Astrocytoma" type: "DX" references: true breadcrumbs:
- "Pediatrics"
- "Diagnosis"
- "Pediatric Neuroradiology"
- "Brain"
- "Pathology-Based Diagnoses"
- "Neoplasms"
- "Pilomyxoid Astrocytoma"
KEY FACTS
-
Terminology
- Pilomyxoid astrocytoma (PMA): More aggressive, myxoid variant of pilocytic astrocytoma (PA) - High risk of local recurrence, CSF dissemination
-
Imaging
- 60% suprasellar (large, bulky, H-shaped mass in hypothalamus/optic chiasm, medial temporal lobes)
- 40% outside diencephalon (hemisphere, ventricles)
- Grossly well circumscribed, little/no edema
- Enhances strongly
- 20% show intratumoral hemorrhage
-
Top Differential Diagnoses
- PA
- High-grade glioma
- Germinoma
-
Pathology
- WHO grade 2 (typical PA is WHO grade 1)
-
Clinical Issues
- Typical: Infants, young children (< 4 years)
- Less common: Older children, young adults
- 5-10% of cases initially diagnosed as PAs may actually be PMAs - Especially if tumor is hemorrhagic, presents in very young child, or shows CSF dissemination
-
Diagnostic Checklist
- Consider PMA if - Infant or young child has large/bulky or hemorrhagic H-shaped suprasellar mass - Presumed PA in any patient who has atypical imaging (e.g., hemorrhage, metastases)
TERMINOLOGY
-
Abbreviations
- Pilomyxoid astrocytoma (PMA)
-
Synonyms
- Myxoid variant of pilocytic astrocytoma (PA)
-
Definitions
- Tumor with monomorphic piloid cells dispersed in mucopolysaccharide-rich matrix - More aggressive tumor than PA with high risk of local recurrence, dissemination
IMAGING
-
General Features
-
Best diagnostic clue
- Infant or young child with large, bulky, H-shaped mass in hypothalamus/optic chiasm, medial temporal lobes -
Location
- 60% suprasellar - Optic chiasm, hypothalamus - Extension into adjacent structures is common with larger tumors - Deep gray nuclei, temporal lobes, adjacent white matter often involved - 40% centered **outside** diencephalon - Cerebral hemispheres - 2nd most common general location - Temporal lobe most common - May be purely cortical - Less common sites reported - Midbrain - Cerebellum - 4th ventricle - Spinal cord -
Size
- Variable - Mean: 4 cm - Often large, bulky (up to 12 cm) -
Morphology
- Grossly well circumscribed
-
-
CT Findings
-
NECT
- Uniform hypodensity most common - 20% show intratumoral hemorrhage - Hyperdense; mixed hypo-/hyperdense - Ca⁺⁺ occurs but uncommon -
CECT
- Strong, but inhomogeneous enhancement - Irregular central nonenhancing area in 1/3
-
-
MR Findings
-
T1WI
- Typical: Uniformly hypointense (almost 2/3 of cases) - Less common: Mixed hypo-/hyperintensity (10-15%) - Uncommon: Blood-fluid level -
T2WI
- 70% uniformly hyperintense - 15% inhomogeneously hyperintense - 10% hypointense center, hyperintense rim -
FLAIR
- 50% uniformly hyperintense - 33% heterogeneously hyperintense - Relatively well-demarcated margins - Little or no peritumoral edema -
T2* GRE
- Intratumoral hemorrhage in 20% - May be strikingly hypointense -
DWI
- Typically does not restrict - ADC signal in solid component usually significantly ↑ compared to brain parenchyma -
PWI
- ASL and DSC PWI may help distinguish PMA from PA - ASL: Mean tumor:GM cerebral blood flow (CBF) ratio = 1.3 in PMA vs. 0.4 in PA - DSC: Relative cerebral blood volume (rCBV) is 2 in PMA vs. 1.5 in PA -
T1WI C+
- Strong but heterogeneous enhancement - 50% heterogeneous (i.e., rim) - 40% solid, homogeneous - 10% no enhancement - Basilar/spinal meningeal enhancement is common and indicates CSF dissemination
-
-
Other Modality Findings
- MRS - ↑ Cho, ↓ Cr and NAA ± lactate - Some authors report low-metabolite pattern with ↓ Cho, Cr, NAA
-
Imaging Recommendations
-
Best imaging tool
- MR with T1 C+, DWI, T2* (GRE or SWI), MRS -
Protocol advice
- Thin-section sagittal, coronal pre- and postcontrast T1WI - Whole-brain FLAIR - Thin-section T2WI through hypothalamus, chiasm - GRE or SWI (to look for hemorrhage) - Optional: Add DWI, MRS
-
DIFFERENTIAL DIAGNOSIS
- Pilocytic Astrocytoma
- Older children (mean age at diagnosis: 6 years)
- In hypothalamus, typically enhances strongly/uniformly
- Occasionally calcified
- Clinically indolent, rarely aggressive
- PMA usually more hyperintense on T2/FLAIR (mucoid matrix)
- Hemorrhage, CSF dissemination uncommon
- Paradoxically aggressive MRS pattern: ↑ Cho, ↓ Cr, ↓ NAA - Some PMAs show low metabolite concentrations
- High-Grade Glioma (Anaplastic Astrocytoma, Glioblastoma)
- Hemorrhage, necrosis common
- Hypothalamus rare location
- Patients usually older
- May arise from lower grade astrocytoma
- Germinoma
- Most often in suprasellar, pineal, or basal ganglia regions
- Numerous microcysts common
- Diffusion restriction of solid components reflects high cellularity
PATHOLOGY
-
General Features
-
Etiology
- Unknown - Some tumors demonstrate synaptophysin reactivity, suggesting PMAs may be of mixed glioneuronal origin - May also originate from tanycytic cells -
Genetics
- PMA has significant differences in gene expression vs. PA - *H19*, *DACT2*, extracellular matrix collagens, *IGF2BP3*(*IMP3*) overexpressed in PMAs - Variable tendencies toward maturation to PA -
Associated abnormalities
- Few cases associated with neurofibromatosis type 1 have been reported
-
-
Staging, Grading, & Classification
- WHO grade 2 (PA is WHO grade 1) - Grade 3 if anaplastic features - Malignant transformation to glioblastoma (grade 4) rare but does occur
- MIB1 generally low (1-2%) but higher in anaplastic pleomorphic xanthoastrocytomas
-
Gross Pathologic & Surgical Features
- Large, grossly well-circumscribed mass
- Necrosis, hemorrhage may be present
-
Microscopic Features
- Lacks classic biphasic pattern seen in PAs - Alternating solid and loose areas interspersed with microcysts not seen - Rosenthal fibers, eosinophilic granular bodies absent
- Consists of monomorphic piloid tumor cells - Embedded in myxoid (mucopolysaccharide-rich) matrix - GFAP (+), vimentin (+)
- Conspicuous angiocentric growth pattern (perivascular rosettes) - Vascular proliferation may be marked - Infiltration of tumor cells into adjacent brain common - Necrosis rare
CLINICAL ISSUES
-
Presentation
-
Most common signs/symptoms
- Signs of ↑ intracranial pressure - Headache - Nausea, vomiting - Delayed development - Failure to thrive (so-called diencephalic syndrome) - Visual disturbances - Hypothalamic dysfunction -
Other signs/symptoms
- Seizures - Focal neurologic deficit
-
-
Demographics
-
Age
- Typical: Infants, young children (< 4 years) - Less common: Older children, young adults - Rare: Middle-aged adult (up to 46 years) -
Sex
- Slight male predominance (M:F = 4:3) -
Epidemiology
- Rare; represent < 1% of astrocytomas - 5-10% of cases initially diagnosed as PAs may be PMAs, especially if hemorrhage is present or tumor presents in very young child
-
-
Natural History & Prognosis
- Higher recurrence rate than PA
- CSF dissemination common
- Bimodal pattern - Can mature to PA - May dedifferentiate into GBM
-
Treatment
- Partial resection with adjuvant therapy may prolong survival
DIAGNOSTIC CHECKLIST
-
Consider
- PMA if - Infant or young child has large/bulky or hemorrhagic suprasellar mass - Imaging atypical for PA (i.e., hemorrhage)
- If PA with repeated recurrences, CSF dissemination, review histopathology and consider PMA
-
Image Interpretation Pearls
- H-shaped suprasellar mass may be PMA
1af64b07-c8e0-4129-92e0-366b39b94ad3
References
Selected References
- AlShail E et al: A molecular study of pediatric pilomyxoid and pilocytic astrocytomas: genome-wide copy number screening, retrospective analysis of clinicopathological features and long-term clinical outcome. Front Oncol. 13:1034292, 2023
- Mbekeani JN et al: Pediatric pilomyxoid astrocytoma - ophthalmic and neuroradiologic manifestations. Eur J Ophthalmol. 32(5):2604-14, 2022
- Benson JC et al: Hypothalamic pilomyxoid astrocytoma in a child with lipodystrophy. AJNR Am J Neuroradiol. 42(8):1370-4, 2021
- Gader G et al: Pediatric cerebellar pilomyxoid astrocytoma: clinical and radiological findings in three cases. Asian J Neurosurg. 15(2):262-5, 2020
- Ho CY et al: Differentiation of pilocytic and pilomyxoid astrocytomas using dynamic susceptibility contrast perfusion and diffusion weighted imaging. Neuroradiology. 62(1):81-8, 2020
- He J et al: Posterior fossa pilomyxoid astrocytoma with spontaneous hemorrhage in pediatric patients. Childs Nerv Syst. 34(1):149-53, 2018
- Louis DN et al: The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131(6):803-20, 2016
- Wang Z et al: Spontaneous intratumoural and intraventricular haemorrhage associated with a pilomyxoid astrocytoma in the hypothalamic/chiasmatic region. J Clin Neurosci. 33:217-20, 2016
- Alkonyi B et al: Differential imaging characteristics and dissemination potential of pilomyxoid astrocytomas versus pilocytic astrocytomas. Neuroradiology. 57(6):625-38, 2015
- Amarasinghe SG et al: A rare case of multicystic disseminated astrocytoma with pilomyxoid characteristics in a 4-year-old child. Childs Nerv Syst. 31(4):625-9, 2015
- Nabavizadeh SA et al: High accuracy of arterial spin labeling perfusion imaging in differentiation of pilomyxoid from pilocytic astrocytoma. Neuroradiology. 57(5):527-33, 2015
- El Beltagy MA et al: Surgical and clinical aspects of cerebellar pilomyxoid-spectrum astrocytomas in children. Childs Nerv Syst. 30(6):1045-53, 2014
- Kleinschmidt-DeMasters BK et al: Pilomyxoid astrocytoma (PMA) shows significant differences in gene expression vs. pilocytic astrocytoma (PA) and variable tendency toward maturation to PA. Brain Pathol. 25(4):429-40, 2015
- Amirjamshidi A et al: Pilomyxoid astrocytoma. J Neurosurg Pediatr. 11(5):613, 2013
- Bhargava D et al: Occurrence and distribution of pilomyxoid astrocytoma. Br J Neurosurg. 27(4):413-8, 2013
- Lee IH et al: Imaging characteristics of pilomyxoid astrocytomas in comparison with pilocytic astrocytomas. Eur J Radiol. 79(2):311-6, 2011
- Johnson MW et al: Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. Am J Surg Pathol. 34(12):1783-91, 2010
- Amatya VJ et al: Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas. Pathol Int. 59(2):80-5, 2009
- Buccoliero AM et al: Occipital pilomyxoid astrocytoma in a 14-year-old girl--case report. Clin Neuropathol. 27(6):373-7, 2008
- Komotar RJ et al: Magnetic resonance imaging characteristics of pilomyxoid astrocytoma. Neurol Res. 30(9):945-51, 2008
- Linscott LL et al: Pilomyxoid astrocytoma: expanding the imaging spectrum. AJNR Am J Neuroradiol. 29(10):1861-6, 2008
- Brat DJ et al: Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol. 17(3):319-24, 2007
- Ceppa EP et al: The pilomyxoid astrocytoma and its relationship to pilocytic astrocytoma: report of a case and a critical review of the entity. J Neurooncol. 81(2):191-6, 2007
- Morales H et al: Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas. J Comput Assist Tomogr. 31(5):682-7, 2007
- Komotar RJ et al: Astrocytoma with pilomyxoid features presenting in an adult. Neuropathology. 26(1):89-93, 2006
- Melendez B et al: BCR gene disruption in a pilomyxoid astrocytoma. Neuropathology. 26(5):442-6, 2006
- Cirak B et al: Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma. Childs Nerv Syst. 21(5):404-9, 2005
- Komotar RJ et al: Pilomyxoid astrocytoma of the spinal cord: report of three cases. Neurosurgery. 56(1):191, 2005
- Chikai K et al: Clinico-pathological features of pilomyxoid astrocytoma of the optic pathway. Acta Neuropathol (Berl). 108(2):109-14, 2004
- Darwish B et al: Juvenile pilocytic astrocytoma 'pilomyxoid variant' with spinal metastases. J Clin Neurosci. 11(6):640-2, 2004
- Komotar RJ et al: Pilomyxoid astrocytoma: a review. MedGenMed. 6(4):42, 2004
- Arslanoglu A et al: MR imaging characteristics of pilomyxoid astrocytomas. AJNR Am J Neuroradiol. 24(9):1906-8, 2003
- Burger PC et al: Pathology of diencephalic astrocytomas. Pediatr Neurosurg. 32(4):214-9, 2000
- Tihan T et al: Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol. 58(10):1061-8, 1999
Images
Selected Images
Coronal graphic depicts a pilomyxoid astrocytoma (PMA). Note the large, bulky, H-shaped mass
centered in the hypothalamic/chiasmatic region and extending into both temporal lobes. The tumor is relatively well circumscribed and shows little/no edema. Glistening myxoid matrix is typical. Hemorrhage
occurs in ~ 20% of PMAs but is unusual in pilocytic astrocytoma (PA).
Coronal graphic depicts a pilomyxoid astrocytoma (PMA). Note the large, bulky, H-shaped mass
centered in the hypothalamic/chiasmatic region and extending into both temporal lobes. The tumor is relatively well circumscribed and shows little/no edema. Glistening myxoid matrix is typical. Hemorrhage
occurs in ~ 20% of PMAs but is unusual in pilocytic astrocytoma (PA).
Coronal T1 C+ MR in a 20-month-old with a PMA shows a large, heterogeneously enhancing hypothalamic mass
.
Sagittal T2 MR in a 7-month-old with a PMA shows a large mass
centered in the hypothalamus and optic chiasm. Note the pituitary
pressed down along the floor of the sella. The large size of the tumor and the very young age of the patient are typical of a PMA.
Axial ADC MR in the same patient shows almost universal increased signal in the tumor
compared to brain parenchyma, which is typical for low-grade astrocytic tumors, such as PMAs.
Sagittal T1 C+ MR in a 2-year-old shows an avidly enhancing hypothalamic tumor
. This is a typical appearance for PMA.
Axial SWI in the same patient shows multifocal areas of signal loss
, consistent with intratumoral microhemorrhage. Microhemorrhage is more common in PMAs compared to PAs. For this reason, it is helpful diagnostically to include SWI in evaluation of hypothalamic tumors.
Sagittal T1 C+ MR in a 23-month-old demonstrates a homogeneously enhancing midbrain lesion
. Pathology revealed a PMA. Regardless of location, PMAs should be considered for any likely low-grade glioma in a very young child.
Coronal T1 C+ MR in a 2-year-old with a uniformly enhancing mass
centered in the right cerebellar hemisphere is shown. Note the associated hydrocephalus
. While the cerebellum is the most common location for PAs, it is an uncommon location for PMAs.
Axial T1 C+ MR in 9-year-old shows a rim-enhancing mass
with lack of adjacent edema. Enhancement patterns of PMAs vary greatly from solid homogeneous enhancement to peripheral enhancement, as seen here. Some degree of enhancement is almost universally present.
Sagittal T1 C+ MR in a 3-year-old with an avidly enhancing intramedullary tumor
, found to be a PMA on pathology, is shown. While uncommon, PMAs have been reported to occur in the spine.
Additional Images
Sagittal T2 MR in the same patient shows a large, lobulated tumor centered in the hypothalamus with exophytic extension of the tumor into the 3rd ventricle
and prepontine cistern
. A suprasellar location is the most common location for a PMA.
Axial ADC map in the same patient shows hyperintense signal within the solid components of the tumor
, which is characteristic of hypothalamic gliomas. There is significant overlap in imaging features of PAs and PMAs.
Sagittal T1 C+ MR in a 9-month-old with macrocephaly shows a large, centrally necrotic mass centered within the hypothalamus with extension into the sella
and 3rd ventricle.
Axial T2 GRE MR in the same patient shows small foci of signal loss
centrally within the lesion, suggesting areas of microhemorrhage. Approximately 20% of PMAs show hemorrhage, which is rare in PAs. Whenever hemorrhage is identified in a hypothalamic glioma, a PMA should be suggested.*
Sagittal T2 MR in a 23-month-old with a PMA shows a homogeneously hyperintense lesion
centered in the midbrain. A PMA can occur anywhere, including the brainstem.
Axial T2 MR in a 9-year-old shows a markedly hyperintense mass
centered in the right basal ganglia, causing obstruction at the foramina of Monro with obstructive hydrocephalus. Pathology revealed a PMA.
Sagittal T1 C+ MR in a 9-year-old shows an enhancing mass projecting into the 3rd ventricle from the thalamus. PMA was diagnosed on biopsy.
Anteroposterior MRA in the same patient shows encasement of the right anterior cerebral artery
and elevation of the middle cerebral artery
compared to the normal left side. No neovascularity was seen. A PMA was found at surgery.
Coronal T1 C+ MR in a 3-year-old shows a large, inhomogeneously enhancing, suprasellar mass encasing the carotid bifurcation
.
Sagittal T2 MR shows a large, hyperintense hypothalamic/optic chiasm mass
. This could be either a pilomyxoid or PA on the basis of imaging findings. A PMA was found at surgery.
Coronal T2 MR in an infant with a large head shows markedly enlarged lateral ventricles and a lobulated, hyperintense suprasellar mass.
Axial FLAIR MR in the same patient shows the large mass
completely fills the suprasellar cistern, elevating and encasing both middle cerebral arteries
. The mass is mildly hyperintense relative to cortex.
Axial T1 C+ SPGR MR in the same patient shows the mass
enhances intensely and quite uniformly. The H-shaped configuration centered in the suprasellar cistern is classic for PMAs, which was confirmed at surgery. (Courtesy M. Thurnher, MD.)
Axial FLAIR MR in a 3-year-old shows a large, H-shaped suprasellar mass with extension into the basal ganglia and both medial temporal lobes. The tumor is quite well delineated despite its size and shows no evidence for surrounding edema.
Axial T1 C+ MR in the same patient shows intense, uniform enhancement.
High-power mucin stain shows the mucinous matrix (blue) with embedded glial nuclei. MIB1 was elevated. Final diagnosis was a PMA (WHO grade II). (Courtesy R. Hewlett, MD.)
Micropathology biopsied from the same patient shows neoplastic, bipolar, "pilocytic" cells. No Rosenthal fibers are seen.
Axial T2 MR in a 20-month-old shows a huge, bulky suprasellar and medial temporal lobe mass. Scattered foci of T2 shortening within the mass
may represent hemorrhage (no T2 imaging was performed.)*
Axial T1 C+ MR in the same patient shows mixed solid and rim enhancement. Biopsy disclosed elongated "piloid" cells in a mucin-rich matrix, consistent with a PMA. (Courtesy R. Hewlett, MD.)